Search results for abx831225

Ficlatuzumab, Abbexa, abx831225

Ficlatuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting HGF, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Ficlatuzumab has been used in trials studying the treatment of Acute Myeloid Leukemia, Non-small Cell Lung Cancer, Mullerian Mixed Tumor of Ovary, Relapsed Acute Myeloid Leukemia, and Refractory Acute Myeloid Leukemia, among others.